Empire Genomics
Leader in the field of molecular diagnostic services for oncology diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD10—15m (Dealroom.co estimates May 2016.)
Town of Lancaster New York (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$142k | Grant | ||
$1.0m | Series A | ||
$1.8m | Series B | ||
N/A | $500k | Debt | |
* | N/A | Acquisition | |
Total Funding | CAD4.0m |
Related Content
Recent News about Empire Genomics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.